Gut microbiota has been shown to systemically shape the immunological landscape, modulate homeostasis and play a role in both health and disease. Dysbiosis of gut microbiota promotes inflammation and contributes to the pathogenesis of several major disorders in gastrointestinal tract, metabolic, neurological and respiratory diseases. Much effort is now focused on understanding host-microbes interactions and new microbiota-targeted therapies are deeply investigated as a means to restore health or prevent disease.This review details the immunoregulatory role of the gut microbiota in health and disease and discusses the most recent strategies in manipulating individual patient's microbiota for the management and prevention of inflammatory conditions.

Microbiota-targeted therapies in inflammation resolution / F. Strati, G. Lattanzi, C. Amoroso, F. Facciotti. - In: SEMINARS IN IMMUNOLOGY. - ISSN 1044-5323. - 59:(2022 Jan), pp. 101599.1-101599.14. [10.1016/j.smim.2022.101599]

Microbiota-targeted therapies in inflammation resolution

G. Lattanzi
Secondo
;
2022

Abstract

Gut microbiota has been shown to systemically shape the immunological landscape, modulate homeostasis and play a role in both health and disease. Dysbiosis of gut microbiota promotes inflammation and contributes to the pathogenesis of several major disorders in gastrointestinal tract, metabolic, neurological and respiratory diseases. Much effort is now focused on understanding host-microbes interactions and new microbiota-targeted therapies are deeply investigated as a means to restore health or prevent disease.This review details the immunoregulatory role of the gut microbiota in health and disease and discusses the most recent strategies in manipulating individual patient's microbiota for the management and prevention of inflammatory conditions.
No
English
FMT; Gut microbiome; Inflammation; Live biotherapeutic products; Mucosal immunity; Probiotics;
Settore MED/07 - Microbiologia e Microbiologia Clinica
Review essay
Esperti anonimi
Pubblicazione scientifica
Goal 3: Good health and well-being
gen-2022
Academic Press : Elsevier
59
101599
1
14
14
Pubblicato
Periodico con rilevanza internazionale
orcid
scopus
pubmed
crossref
wos
datacite
Aderisco
info:eu-repo/semantics/article
Microbiota-targeted therapies in inflammation resolution / F. Strati, G. Lattanzi, C. Amoroso, F. Facciotti. - In: SEMINARS IN IMMUNOLOGY. - ISSN 1044-5323. - 59:(2022 Jan), pp. 101599.1-101599.14. [10.1016/j.smim.2022.101599]
reserved
Prodotti della ricerca::01 - Articolo su periodico
4
262
Article (author)
Periodico con Impact Factor
F. Strati, G. Lattanzi, C. Amoroso, F. Facciotti
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S1044532322000161-main.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 867.8 kB
Formato Adobe PDF
867.8 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/958236
Citazioni
  • ???jsp.display-item.citation.pmc??? 5
  • Scopus 10
  • ???jsp.display-item.citation.isi??? 6
social impact